Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

News headlines Vertex Pharmaceuticals (VRTX) faces mixed performance as it prepares for a highly anticipated earnings release. While long-term revenue growth remains strong at 14.4% annually, recent ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

convert the numbers from standard form into decimal form or ordinary numbers complete the calculation convert the answer back into standard form Calculate \((4 \times 10^9) \times (7 \times 10^{-3})\) ...

See how your savings and investment account balances can grow with the magic of compound interest. Many, or all, of the products featured on this page are from our advertising partners who compensate ...

CBS shelves ‘60 Minutes’ story on Trump deportees at the last minute: ‘People are threatening to quit,’ staffers say ...

Learn how to gain control of your saving and spending Are you struggling to keep your spending below your income? Do you strategize about how to increase your savings? Our free budgeting calculator ...